Solara Active Pharma Sciences Ltd.

Financial

	Solara Active Pharma	Morepen Laboratories	Bajaj Healthcare
Operational Metrics
API Sector
Manufacturing Capacity - Ibuprofen	5000.0 MTPA	n/a	n/a
US DMF Filings	230.0 .	n/a	n/a
Financials
5 yr Average ROE	-8.31 %	13.75 %	9.93 %
5yr average Equity Multiplier	1.98	1.84	2.26
5yr Average Asset Turnover Ratio	0.55	1.34	0.95
5yr Avg Net Profit Margin	-5.56 %	5.42 %	3.65 %
Price to Book	2.35	2.44	4.76
P/E	0.0	21.53	0.0
5yr Avg Cash Conversion Cycle	115.03 Days	21.38 Days	15.4 Days
Inventory Days	106.31 Days	53.55 Days	51.52 Days
Days Receivable	125.38 Days	63.5 Days	72.17 Days
Days Payable	142.19 Days	98.41 Days	83.01 Days
5yr Average Interest Coverage Ratio	0.55	39.33	7.11
5yr Avg ROCE	3.01 %	15.84 %	24.2 %
5yr Avg Operating Profit Margin	10.34 %	8.37 %	16.67 %
5 yr average Debt to Equity	0.69	0.04	0.86
5yr CAGR Net Profit	n/a	23.42 %	n/a
5yr Average Return on Assets	-2.61 %	7.36 %	5.32 %
Shareholdings
Promoter Holding	37.23 %	35.65 %	59.19 %
Share Pledged by Promoters	40.74 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-2.28 %	1.11 %	-8.07 %
Change in Mutual Fund Holding (3 Yrs)	-3.57 %	0.0	1.64 %

Business

	Solara Active Pharma	Morepen Laboratories	Bajaj Healthcare
Product Wise Break-Up	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 100.0 Ibuprofen 0 OTC 0 Finished Formulations 0 Home Diagnostics / Health 0 0 Formulations 0 Bulk Drugs 0	Product Wise Break-Up Bulk Drugs 0 Finished Formulations 0 OTC 0 Home Diagnostics / Health 26.86 Formulations 0 Ibuprofen 0 Active Pharmaceutical Ingredient (API) 73.14 Active Pharmaceutical Ingredient (API) 0	Product Wise Break-Up Bulk Chemicals 100.0 Finished Formulations 0 OTC 0 Home Diagnostics / Health 0 Formulations 0 Ibuprofen 0 0 Active Pharmaceutical Ingredient (API) 0
Location Wise Break-Up	Location Wise Break-Up Asia Pacific 55.91 Europe 23.03 North America 6.76 South America 0.45 India 0 Rest of the World 0 USA 0 Others 13.85	Location Wise Break-Up USA 4.4 India 29.7 Asia Pacific 0 North America 0 Europe 22.0 Rest of the World 0 South America 14.8 Others 29.1	Location Wise Break-Up USA 0 India 75.88 Asia Pacific 0 North America 0 Europe 0 Rest of the World 24.12 South America 0
Asset Break-Up	Asset Break-Up India 100.0 Formulations 0 Bulk Drugs 0	-	Asset Break-Up Active Pharmaceutical Ingredient (API) 90.29 India 0 Formulations 9.71